Markets:

Overview

News

Currencies

International

Treasuries

Metsera, Inc. - Common Stock (NQ:MTSR)

70.50 UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Metsera, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

What's Pfizer Getting in Its $7.3 Billion Metsera Buyout? ↗

September 23, 2025

Pfizer's plan to enter the booming obesity market took an expensive new turn.

Via The Motley Fool

Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says BTIG — Retail Slams Rivals For Buying ‘Inferior Pipelines’ ↗

September 22, 2025

BTIG said Pfizer’s $7.3 billion Metsera acquisition sharpens its clinical updates and strategic optionality.

Via Stocktwits

Top stock movements in today's session. ↗

September 22, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Nvidia, Metsera, Oracle, Apple, Compass: Stocks Making The Biggest Moves Today ↗

September 22, 2025

Via Stocktwits

Pfizer Stock Draws Focus On Report Of $7.3B Deal Plan For Metsera Buyout As Obesity Drug Race With Lilly, Novo Heats Up ↗

September 22, 2025

Via Stocktwits

Why Pfizer Stock Just Popped ↗

September 22, 2025

Pfizer's own GLP-1 drug candidate failed earlier this year -- so it's buying someone else's.

Via The Motley Fool

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)

September 22, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 22, 2025

Via Benzinga

Top movers analysis in the middle of the day on 2025-09-22: top gainers and losers in today's session. ↗

September 22, 2025

Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Gold Gains Over 1%; Quantum Computing Shares Plunge ↗

September 22, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

September 22, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

PROS Holdings, MBX Biosciences, Metsera, Anywhere Real Estate And Other Big Stocks Moving Higher On Monday ↗

September 22, 2025

Via Benzinga

Pfizer Claws Deeper Into The Obesity Space With $4.9 Billion Metsera Deal ↗

September 22, 2025

The deal follows two high-profile failures for Pfizer, which is trying to broaden its small pipeline in weight loss.

Via Investor's Business Daily

Pfizer Tries To Revitalize Obesity Portfolio With $5 Billion Matsera Deal ↗

September 22, 2025

Pfizer will buy Metsera for $4.9 billion plus milestone payments, adding incretin, amylin, and oral obesity drug candidates to its pipeline.

Via Benzinga

Monday's pre-market session: top gainers and losers ↗

September 22, 2025

The US market session of Monday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 22, 2025

Via Benzinga

MTSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Metsera, Inc. Is Fair to Shareholders

September 22, 2025

From Halper Sadeh LLC

Via Business Wire

Pfizer Reportedly Nears Metsera Acquisition Deal: PFE Stock Climbs In Monday Pre-Market ↗

September 22, 2025

Pfizer Inc. (NYSE: PFE) stock climbed 1.87% in Monday pre-market amid reports that the company on the verge of acquiring Metsera Inc. (NASDAQ: MTSR), a developer of anti-obesity drugs.

Via Benzinga

Metsera Stock Surges 59% Pre-Market After Pfizer Confirms Acquisition – Here Are The Details ↗

September 22, 2025

The upfront purchase price of $47.50 per share implies a premium of 43% from Metsera’s closing share price on Friday.

Via Stocktwits

Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio

September 22, 2025

From Pfizer Inc.

Via Business Wire

Why MBX Biosciences Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket ↗

September 22, 2025

Via Benzinga

Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting

September 11, 2025

From Metsera, Inc.

Via GlobeNewswire

Metsera to Present at Upcoming September Investor Conferences

August 27, 2025

From Metsera, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 28, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Monday? ↗

July 28, 2025

After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Via Chartmill

Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress

July 28, 2025

From Metsera, Inc.

Via GlobeNewswire

ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

July 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 18, 2025

Via Benzinga

Methode Electronics, Ultragenyx Pharmaceutical And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

July 10, 2025

Via Benzinga

Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday ↗

July 09, 2025

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.